ArticleActa pharmaceutica Sinica. B2023
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia.
Zhifu Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it